Literature DB >> 18022384

Impairment of microtubule system increases alpha-synuclein aggregation and toxicity.

Myunghye Kim1, Wonsuk Jung, In-Hwan Lee, Ghibom Bhak, Seung R Paik, Ji-Sook Hahn.   

Abstract

The accumulation of fibrillar form of alpha-synuclein (alpha-syn) has been implicated in Parkinson's disease. Here we show that tubulin can stimulate alpha-syn fibrillization in vitro in different ways depending on its oligomeric status. The physiological significance of tubulin-seeded alpha-syn fibrillization is demonstrated by using Saccharomyces cerevisiae as a model system. Perturbation of microtubule system either by treating benomyl that inhibits microtubule assembly or by deleting genes involved in microtubule biogenesis, stimulates alpha-syn aggregation and toxicity. These results suggest that impairment of the microtubule system may act as a risk factor deteriorating the alpha-syn-mediated neurodegeneration by increasing the chance of tubulin-seeded alpha-syn aggregation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18022384     DOI: 10.1016/j.bbrc.2007.11.020

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  12 in total

1.  A pilot trial of the microtubule-interacting peptide (NAP) in mice overexpressing alpha-synuclein shows improvement in motor function and reduction of alpha-synuclein inclusions.

Authors:  Sheila M Fleming; Caitlin K Mulligan; Franziska Richter; Farzad Mortazavi; Vincent Lemesre; Carmen Frias; Chunni Zhu; Alistair Stewart; Illana Gozes; Bruce Morimoto; Marie-Françoise Chesselet
Journal:  Mol Cell Neurosci       Date:  2010-12-27       Impact factor: 4.314

2.  Coupling surface plasmon resonance to mass spectrometry to discover novel protein-protein interactions.

Authors:  Alexandra Madeira; Elisabet Ohman; Anna Nilsson; Benita Sjögren; Per E Andrén; Per Svenningsson
Journal:  Nat Protoc       Date:  2009-06-11       Impact factor: 13.491

3.  The function of α-synuclein.

Authors:  Jacob T Bendor; Todd P Logan; Robert H Edwards
Journal:  Neuron       Date:  2013-09-18       Impact factor: 17.173

4.  α-Synuclein oligomers impair neuronal microtubule-kinesin interplay.

Authors:  Iryna Prots; Vanesa Veber; Stefanie Brey; Silvia Campioni; Katrin Buder; Roland Riek; Konrad J Böhm; Beate Winner
Journal:  J Biol Chem       Date:  2013-06-06       Impact factor: 5.157

5.  A prolyl oligopeptidase inhibitor, KYP-2047, reduces α-synuclein protein levels and aggregates in cellular and animal models of Parkinson's disease.

Authors:  T T Myöhänen; M J Hannula; R Van Elzen; M Gerard; P Van Der Veken; J A García-Horsman; V Baekelandt; P T Männistö; A M Lambeir
Journal:  Br J Pharmacol       Date:  2012-06       Impact factor: 8.739

6.  Wild-Type Monomeric α-Synuclein Can Impair Vesicle Endocytosis and Synaptic Fidelity via Tubulin Polymerization at the Calyx of Held.

Authors:  Kohgaku Eguchi; Zacharie Taoufiq; Oliver Thorn-Seshold; Dirk Trauner; Masato Hasegawa; Tomoyuki Takahashi
Journal:  J Neurosci       Date:  2017-06-02       Impact factor: 6.167

7.  Microtubule depolymerization potentiates alpha-synuclein oligomerization.

Authors:  A Raquel Esteves; Daniela M Arduíno; Russell H Swerdlow; Catarina R Oliveira; Sandra M Cardoso
Journal:  Front Aging Neurosci       Date:  2010-01-04       Impact factor: 5.750

8.  Cross-talk between mitochondria and proteasome in Parkinson's disease pathogenesis.

Authors:  Diogo Martins Branco; Daniela M Arduino; A Raquel Esteves; Diana F F Silva; Sandra M Cardoso; Catarina Resende Oliveira
Journal:  Front Aging Neurosci       Date:  2010-05-21       Impact factor: 5.750

9.  αSynuclein and Mitochondrial Dysfunction: A Pathogenic Partnership in Parkinson's Disease?

Authors:  David Protter; Charmaine Lang; Antony A Cooper
Journal:  Parkinsons Dis       Date:  2012-06-10

10.  Yeast reveal a "druggable" Rsp5/Nedd4 network that ameliorates α-synuclein toxicity in neurons.

Authors:  Daniel F Tardiff; Nathan T Jui; Vikram Khurana; Mitali A Tambe; Michelle L Thompson; Chee Yeun Chung; Hari B Kamadurai; Hyoung Tae Kim; Alex K Lancaster; Kim A Caldwell; Guy A Caldwell; Jean-Christophe Rochet; Stephen L Buchwald; Susan Lindquist
Journal:  Science       Date:  2013-10-24       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.